Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand?

Red flags have recently been raised concerning the growing burden of non-alcoholic steatohepatitis (NASH) in liver transplantation. Interestingly most large studies on NASH in liver transplantation have come from the US for at least two reasons. Firstly, there has been a more rapid increase in the prevalence of obesity and type-2 diabetes mellitus, two major risk factors for non-alcoholic liver disease (NAFLD) and NASH, in the US than in European and Asian countries.1 The burden of NAFLD/NASH is currently higher in the US than in Europe, as the US has the highest number of obese adults in the world.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research